Publications

5600 Results

Prevalence of HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV) Among Newly Diagnosed Cancer Patients Treated in Academic and Community Oncology Practices

Authors
S Ramsey;J Unger;L Baker;R Little;R Loomba;J Hwang;R Chugh;M Konerman;K Arnold;D Hershman
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr 6600); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster session
Year
2018
Research Committee(s)
Cancer Care Delivery
Study Number(s)
S1204

Standard vs High-dose Carfilzomib (Cfz) with Dexamethasone (Dex) for Relapsed/Refractory Multiple Myeloma (RRMM): Results of S1304, An Intergroup Study

Authors
S Ailawadhi;R Sexton;S Lentzsch;M Abidi;P Voorhees;AD Cohen;EM Rohren;S Heitner;K Kelly;N Mackler;D Baer;A Hoering;B Durie;R Orlowski
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr 8015); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster discussion
Year
2018
Research Committee(s)
Myeloma
Study Number(s)
S1304

First comprehensive report of impact of genomic alterations, chemotherapy, targeted therapy and immunotherapy on outcomes in the genomics driven squamous master protocol LungMAP

Authors
V Papadimitrakopoulou;M Redman;D Gandara;F Hirsch;P Mack;C Langer;M Edelman;C Aggarwal;M Socinski;S Gettinger;SN Waqar;K Griffin;N Leighl;T Owonikoko;JD Bradley;S Ramalingam;T Stinchcombe;C Blanke;K Kelly;R Herbst
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr 9019); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster discussion, abst. 9019
Year
2018
Research Committee(s)
Lung
Study Number(s)
S1400

Prevalence and prognosis of DNA repair deficiency in squamous cell carcinoma (SCC) patients enrolled on the S1400 LungMAP study

Authors
T Owonikoko;M Redman;L Byers;K Griffin;F Hirsch;P Mack;D Gandara;JD Bradley;T Stinchcombe;K Kelly;S Ramalingam;R Herbst;V Papadimitrakopoulou
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr 9055); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster 9055
Year
2018
Research Committee(s)
Lung
Study Number(s)
S1400, S1400G

SWOG S1505: A Randomized Phase II Study of Perioperative mFOLFIRINOX vs. Gemcitabine/nab-Paclitaxel as Therapy for Resectable Pancreatic Adenocarcinoma

Authors
D Sohal;S McDonough;S Ahmad;N Gandhi;MS Beg;A Wang-Gillam;K Guthrie;A Lowy;P Philip;H Hochster
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr TPS4153); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster session
Year
2018
Research Committee(s)
Gastrointestinal
Study Number(s)
S1505

SWOG S1512: A phase II and pilot trial of PD-1 blockade with pembrolizumab in patients with resectable or unresectable desmoplastic melanoma (DM)

Authors
K Kendra;J Moon;S Hu-Lieskovan;W Carson;D Campos;A Cochran;A Ribas
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr TPS9608)ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster session
Year
2018
Research Committee(s)
Melanoma
Study Number(s)
S1512

Clinical Trial in Progress: Reversing resistance to PD-1 blockade by combination of talimogene laherparepvec (T-VEC) with pembrolizumab (pembro) in advanced melanoma patients following progression on a prior PD-1 inhibitor: SWOG S1607 (NCT#02965716)

Authors
S Hu-Lieskovan;J Moon;A Lau Clark;K Grossmann;J Sosman;D Campos;M Wu;C Ryan;A Ribas
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr TPS9603); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster
Year
2018
Research Committee(s)
Melanoma
Study Number(s)
S1607

A Randomized Phase II Study of Trastuzumab and Pertuzumab (TP) Compared to Cetuximab and Irinotecan (CETIRI) in Advanced/Metastatic Colorectal Cancer (mCRC) with HER2 Amplification: SWOG S1613

Authors
K Raghav;S McDonough;B Tan;CS Denlinger;A Magliocco;N Choong;N Sommer;F Scappaticci;D Campos;K Guthrie;ES Kopetz;M Fakih;H Hochster
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr TPS3620)ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster session
Year
2018
Research Committee(s)
Gastrointestinal
Study Number(s)
S1613

Clinical Trial in Progress: Combining ipilimumab (ipi) and nivolumab (nivo) in advanced melanoma following progression on a PD-1 inhibitor (SWOG S1616)

Authors
A VanderWalde;M Latkovic-Taber;S Hu-Llieskovan;K Grossmann;J Sosman;D Campos;M Wu;A Ribas
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr TPS9597); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster session
Year
2018
Research Committee(s)
Melanoma
Study Number(s)
S1616

Case-only analyses for identifying genotypes that modify the effect of finasteride in the Prostate Cancer Prevention Trial (PCPT): SWOG S9217

Authors
JY Dai;M Leblanc;P Goodman;MS Lucia;I Thompson;C Tangen
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr 1551); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster
Year
2018
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217